PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan.\', \'Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan; Solomont School of Nursing, Zuckerberg College of Health Sciences, University of Massachusetts Lowell, 113 Wilder Street, Lowell, MA 01854, USA.\', \'State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, School of Chemistry and Pharmacy, Guangxi Normal University, Guilin 541004, PR China.\', \'Graduate Institute of Biomedical Sciences and Research Center for Cancer Biology, China Medical University, Taichung 406040, Taiwan.\', \'Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan; Biomedical Translational Research Center, Academia Sinica, Taipei, Taiwan.\', \'Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan. Electronic address: cwli@ibms.sinica.edu.tw.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S2352-3964(21)00506-510.1016/j.ebiom.2021.103712
?:hasPublicationType
?:journal
  • EBioMedicine
is ?:pmid of
?:pmid
?:pmid
  • 34839261
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.895
?:rankingScore_hIndex
  • 26
is ?:relation_isRelatedTo_publication of
?:title
  • Targeting conserved N-glycosylation blocks SARS-CoV-2 variant infection in vitro.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all